Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism


Organisms encounter a wide range of foreign compounds—or ‘xenobiotics’—with potentially harmful consequences. The cytochrome P450 (CYP) enzymes metabolize xenobiotics and thus are a primary defence against these compounds. Increased expression of specific CYP genes in response to particular xenobiotics is a central component of this defence1, although such induction can also increase production of toxic metabolites. Here we show that the nuclear receptor CAR mediates the response evoked by a class of xenobiotics known as the ‘phenobarbital-like inducers’. The strong activation of Cyp2b10 gene expression by phenobarbital, or by the more potent TCPOBOP, is absent in mice lacking the CAR gene. These animals also show decreased metabolism of the classic CYP substrate zoxazolamine and a complete loss of the liver hypertrophic and hyperplastic responses to these inducers. Cocaine causes acute hepatotoxicity in wild-type mice previously exposed to phenobarbital-like inducers and this toxicity is also absent in the CAR-deficient animals. Thus, loss of CAR function alters sensitivity to toxins, increasing or decreasing it depending on the compound. Modulation of CAR activity in humans may significantly affect metabolism of drugs and other xenobiotics.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Targeted disruption of the mouse CAR gene.
Figure 2: Xenobiotic activation of the Cyp2b10 gene by CAR.
Figure 3: Liver enlargement and hepatocyte proliferation caused by PB or TCPOBOP.
Figure 4: Effect of PB or TCPOBOP on cocaine-mediated hepatotoxicity.


  1. 1

    Waxman, D. J. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys. 369, 11–23 (1999).

    CAS  Article  Google Scholar 

  2. 2

    Poland, A. et al. 1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, a potent phenobarbital-like inducer of microsomal monooxygenase activity. Mol. Pharmacol. 18, 571–580 (1980).

    CAS  PubMed  Google Scholar 

  3. 3

    Honkakoski, P., Zelko, I., Sueyoshi, T. & Negishi, M. The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene. Mol. Cell. Biol. 18, 5652–5658 (1998).

    CAS  Article  Google Scholar 

  4. 4

    Sueyoshi, T., Kawamoto, T., Zelko, I., Honkakoski, P. & Negishi, M. The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene. J. Biol. Chem. 274, 6043–6046 (1999).

    CAS  Article  Google Scholar 

  5. 5

    Tzameli, I., Pissios, P., Schuetz, E. G. & D, Moore, D. D. The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR. Mol. Cell. Biol. 20, 2951–2958 (2000).

    CAS  Article  Google Scholar 

  6. 6

    Jones, S. A. et al. The pregnane X receptor: a promiscuous xenobiotic receptor that has diverged during evolution. Mol. Endocrinol. 14, 27–39 (2000).

    CAS  Article  Google Scholar 

  7. 7

    Moore, L. B. et al. Orphan nuclear receptors, constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J. Biol. Chem. 275, 15122–15127 (2000).

    CAS  Article  Google Scholar 

  8. 8

    Baes, M. et al. A new orphan member of the nuclear receptor superfamily that interacts with a subset of retinoic acid response elements. Mol. Cell. Biol. 14, 1544–1552 ( 1994).

    CAS  Article  Google Scholar 

  9. 9

    Choi, H. S. et al. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J. Biol. Chem. 272, 23565–23571 (1997).

    CAS  Article  Google Scholar 

  10. 10

    Heubel, F., Reuter, T. & Gerstner, E. Differences between induction effects of 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene and phenobarbitone. Biochem. Pharmacol. 38, 1293–1300 (1989).

    CAS  Article  Google Scholar 

  11. 11

    Carthew, P., Edwards, R. E. & Nolan, B. M. The quantitative distinction of hyperplasia from hypertrophy in hepatomegaly induced in the rat liver by phenobarbital. Toxicol. Sci. 44, 46–51 (1998).

    CAS  Article  Google Scholar 

  12. 12

    Cunningham, M. L. Role of increased DNA replication in the carcinogenic risk of nonmutagenic chemical carcinogens. Mutat. Res. 365, 59 –69 (1996).

    Article  Google Scholar 

  13. 13

    Robinson, J. R. & Nebert, D. W. Genetic expression of aryl hydrocarbon hydroxylase induction. Presence or absence of association with zoxazolamine, diphenylhydantoin, and hexobarbital metabolism. Mol. Pharmacol. 10, 484–493 (1974).

    CAS  PubMed  Google Scholar 

  14. 14

    Bornheim, L. M. Effect of cytochrome P450 inducers on cocaine-mediated hepatotoxicity. Toxicol. Appl. Pharmacol. 150, 158– 165 (1998).

    CAS  Article  Google Scholar 

  15. 15

    Kliewer, S. A. et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell 92, 73–82 (1998).

    CAS  Article  Google Scholar 

  16. 16

    Blumberg, B. et al. SXR, a novel steroid and xenobiotic-sensing nuclear receptor. Genes Dev. 12, 3195–3205 (1998).

    CAS  Article  Google Scholar 

  17. 17

    Lehmann, J. M. et al. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J. Clin. Invest. 102, 1016–1023 (1998).

    CAS  Article  Google Scholar 

  18. 18

    Xie, W. et al. Humanized xenobiotic response in mice expressing nuclear receptor SXR. Nature 406, 435–439 (2000).

    ADS  CAS  Article  Google Scholar 

  19. 19

    Shimada, T., Yamazaki, H., Mimura, M., Inui, Y. & Guengerich, F. P. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther. 270, 414– 423 (1994).

    CAS  PubMed  Google Scholar 

  20. 20

    Code, E. L. et al. Human cytochrome P4502B6: interindividual hepatic expression, substrate specificity, and role in procarcinogen activation. Drug Metab. Dispos. 25, 985–993 (1997).

    CAS  PubMed  Google Scholar 

  21. 21

    Selim, K. & Kaplowitz, N. Hepatotoxicity of psychotropic drugs. Hepatology 29, 1347– 1351 (1999).

    CAS  Article  Google Scholar 

  22. 22

    Liang, H. C. et al. Cyp1a2(-/-) null mutant mice develop normally but show deficient drug metabolism. Proc. Natl Acad. Sci. USA 93, 1671–1676 (1996).

    ADS  CAS  Article  Google Scholar 

Download references


This work was supported by a grant from NIH to D.D.M. We thank F. DeMayo for help with generating the knockout animals.

Author information



Corresponding author

Correspondence to David D. Moore.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wei, P., Zhang, J., Egan-Hafley, M. et al. The nuclear receptor CAR mediates specific xenobiotic induction of drug metabolism. Nature 407, 920–923 (2000).

Download citation

Further reading


By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing